Evrenzo® (roxadustat) tablets approved in Japan for treatment of anemia with CKD
Astellas Pharma and FibroGen announced that Japan's Ministry of Health, Labour and Welfare approved Evrenzo® (generic name: roxadustat) for the treatment of anemia associated with chronic kidney disease in dialysis patients. September 20, 2019